IRCCS Azienda Ospedaliero-Universitaria di Bologna

• NCT07276100

  Phase 2, Recruiting, 15 people, 10 Dec 2025

• NCT05395962

  Phase 2, Recruiting, 92 people, 27 May 2022

• NCT03645603

  Phase 2, Terminated, 45 people, 24 Aug 2018

• NCT02745639

  Phase 2, Completed, 18 people, 20 Apr 2016

• NCT02431663

  Collaborator, Phase 3, Terminated, 57 people, 1 May 2015

• NCT01341262

  Phase 2, Completed, 378 people, 25 Apr 2011

• NCT00571636

  Phase 3, Completed, 128 people, 12 Dec 2007

• European Commission

  HORIZON-RIA, SGLT2 INHIBITION FOR CARDIOVASCULAR ENDPOINT REDUCTION IN HYPERTENSION (SGLT2-HYPE), 101156555, €89.9k, 2025–2032, 10 Dec 2024

Sources: cordis.europa.eu